✓
Open
21 Dec 2023
✓
Close
26 Dec 2023
3
Allotment
—
✓
Listing
Fri, Dec 29, 2023
Price Band
₹426 to ₹448
Issue Size
1,27,23,214 shares (agg. up to ₹570 Cr)
Lot Size
33 Shares
Listing Date
Fri, Dec 29, 2023
Latest GMP
₹32
Est. Gain
7.14%
✦ AI Insight
GMP Trend
29-12-2023₹32Est. ₹480+7.14%
28-12-2023₹32Est. ₹480+7.14%
27-12-2023₹86Est. ₹534+19.2%
Live Subscription
| Category | Subscription (times) |
|---|---|
| Total | 39.17x |
Restated Financials (₹ Cr.)
| Period Ended | 30 Jun 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|---|
| Assets | 1,086.16 | 704.41 | 575.48 | 369.62 |
| Total Income | 234.37 | 935.58 | 803.41 | 412.03 |
| Profit After Tax | 17.59 | 67.95 | 63.95 | 34.50 |
| NET Worth | 294.27 | 276.46 | 208.56 | 144.78 |
| Reserves and Surplus | 317.51 | 228.51 | 196.61 | 132.82 |
| Total Borrowing | 441.90 | 235.19 | 198.18 | 45.03 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Blue Jet Healthcare Ltd. | Mainboard | ₹840.27 Cr | ₹346 | 37.49 | ₹413.40 | +19.48% | ₹581.50 |
| Valiant Laboratories Ltd. | Mainboard | ₹152.46 Cr | ₹140 | 15.71 | ₹170.25 | +21.61% | ₹114.13 |
| Concord Biotech Ltd. | Mainboard | ₹1,550.52 Cr | ₹741 | 32.29 | ₹942.80 | +27.23% | ₹1,470.50 |
| Mankind Pharma Ltd. | Mainboard | ₹4,326.36 Cr | ₹1080 | 32.5 | ₹1,080.00 | +0.00% | ₹2,309.00 |
| Sunrest Lifescience Ltd. | SME | ₹10.85 Cr | ₹84 | 12.33 | ₹79.80 | -5.00% | ₹39.00 |
| Mono Pharmacare Ltd. | SME | ₹14.84 Cr | ₹28 | null | ₹30.45 | +8.75% | ₹9.00 |
| Shelter Pharma Ltd. | SME | ₹16.03 Cr | ₹42 | 5.62 | ₹41.96 | -0.10% | ₹31.00 |
| Vilin Bio Med Ltd. | SME | ₹12.00 Cr | ₹30 | 24.59 | ₹28.50 | -5.00% | ₹59.75 |
| Remus Pharmaceuticals Ltd. | SME | ₹47.69 Cr | ₹1229 | 21.09 | ₹1,796.80 | +46.20% | ₹912.75 |
| Infinium Pharmachem Ltd. | SME | ₹25.25 Cr | ₹135 | 7.83 | ₹147.80 | +9.48% | ₹277.45 |
| Sotac Pharmaceuticals Ltd. | SME | ₹33.30 Cr | ₹111 | 132.14 | ₹120.75 | +8.78% | ₹90.05 |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Repayment and/or prepayment, in part or in full, of certain outstandingloans of the Company | 144.40 |
| 2 | Investment in our Subsidiary, UML, for repayment and / or prepayment in part or full of outstanding loans availed by UML | 23.60 |
| 3 | Funding the working capital requirements | 72.00 |
| 4 | General corporate purposes | 53.11 |
About Innova Captab IPO
Updated on Aug 5, 2026
Contact Details
Innova Captab Ltd. Address601, ProximaPlot No.19, Sector30 A, VashiNavi Mumbai, Maharashtra, 400705+91 22 2564 2095investors@innovacaptab.comVisit Website